Latest news about Fabino Enterprises
Fabino Enterprises
20.31
0.00(0.00%)
Company Performance:
View Company Insights1D0.00%
1M0.00%
6M0.00%
1Y0.00%
5Y0.00%
More news about Fabino Enterprises
23May 26
Fabino FY26 Net Loss Rs 35.97 Cr, Revenue Declines
Fabino Enterprises announced its audited financial results for the year ended March 31, 2026, reporting a consolidated net loss of ₹55.87 crore compared to a net profit of ₹6.11 crore in the previous year. Standalone net loss was ₹35.97 crore, with revenue from operations falling to ₹114.28 crore from ₹180.36 crore in FY25. Key audit matters included write-offs of trade receivables and expired inventory.
13May 26
Open Offer for 26.00% Stake in Fabino Enterprises Limited at ₹20 Per Share by R G Family Trust, Sameer Gupta and Sundeep Gupta
R G Family Trust, Sameer Gupta, and Sundeep Gupta have launched a mandatory open offer to acquire 5,46,000 equity shares (26.00%) of Fabino Enterprises Limited at ₹20/- per share in cash, following a Share Purchase Agreement to acquire 56.82% of the company's equity from promoter-group sellers at ₹18/- per share aggregating ₹2,14,77,600/-. The total offer consideration assuming full acceptance is ₹1,09,20,000/-, with an escrow of ₹30,00,000/- deposited with Yes Bank Limited. The tendering period is scheduled from June 22, 2026 to July 06, 2026, with consideration payment by July 20, 2026. Assuming full acceptance, the acquirers will hold 82.82% of Fabino Enterprises Limited's equity share capital post-offer.
06May 26
Fabino Enterprises Open Offer for 26% Stake at ₹20/Share Scheduled June 22–July 06, 2026
R G Family Trust, Sameer Gupta, and Sundeep Gupta have launched an open offer to acquire 5,46,000 equity shares (26%) of Fabino Enterprises Limited at ₹20 per share, aggregating ₹109.20 Lakhs, under SEBI (SAST) Regulations. The offer is triggered by an SPA dated April 28, 2026 to acquire 56.82% promoter stake at ₹18 per share (₹214.78 Lakhs). The tendering period is scheduled from June 22, 2026 to July 06, 2026, with ₹30,00,000 deposited in escrow with Yes Bank Limited.
11Apr 26
Fabino Enterprises Ltd. Confirms Non-Applicability of SEBI Large Corporate Framework for FY2027
Fabino Enterprises Ltd. has disclosed to BSE Limited that it does not fall under SEBI's Large Corporate category as of March 31, 2026, exempting it from filing disclosures under the framework for FY2026-27. The company, formerly known as Fabino Life Sciences Ltd., confirmed its non-applicability status through a formal communication signed by Managing Director Aditya Mahavir Jain on April 11, 2026. The disclosure addresses SEBI's revised framework circular dated October 19, 2023, ensuring regulatory compliance and transparency regarding the company's status.
11Apr 26
Fabino Enterprises Ltd. Submits Q4FY26 Compliance Certificate to BSE
Fabino Enterprises Ltd. submitted its Q4FY26 compliance certificate to BSE on April 11, 2026, confirming non-applicability of SEBI Regulation 74(5) as all company shares remain in dematerialized form. The certificate, issued by registrar Bigshare Services Private Limited, reported no rematerialization or dematerialization requests during the quarter ended March 31, 2026, indicating complete digitization of the shareholding structure.
10Apr 26
Sushma Shekhar Acquires 8.29% Stake in Fabino Enterprises Through Open Market Purchase
Sushma Shekhar acquired 174,000 shares (8.29%) of Fabino Enterprises Ltd. through open market purchase on April 9, 2026. The acquirer, who is not part of the promoter group, previously held no shares in the BSE-listed company. The acquisition has been disclosed under SEBI Regulation 29, with the company's equity capital remaining at INR 2,10,00,000 divided into 21,00,000 shares of INR 10 each.
26Dec 25
Fabino Enterprises Independent Director Mr. Kuldeep Solanki Resigns with Immediate Effect
Fabino Enterprises Limited announced the immediate resignation of Non-Executive Independent Director Mr. Kuldeep Solanki (DIN: 07109951) effective December 26, 2025, citing pre-occupation and personal commitments. The company has informed BSE Limited under Regulation 30 of SEBI Listing Regulations and confirmed that succession planning will be addressed in the upcoming Board meeting.
26Dec 25
Fabino Enterprises Appoints Deepali Singla as Independent Director
Fabino Enterprises Limited has appointed Mrs. Deepali Singla (DIN: 11442242) as Additional Non-Executive Independent Director effective December 26, 2025, following a board meeting. She brings over six years of professional experience as an Associate at United Lex, specializing in document review, legal research, and regulatory compliance with exposure to Supreme Court and Delhi High Court proceedings.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Zydus Life Science
Cipla
Laurus Labs
Dr Reddys Laboratories
Aurobindo Pharma
Lupin
Mankind Pharma
1,840.00
(-1.13%)
9,322.00
(-1.23%)
4,965.50
(+0.72%)
1,119.10
(+0.12%)
1,366.00
(-0.53%)
1,969.00
(+1.23%)
1,165.50
(+1.97%)
1,679.80
(+0.68%)
2,095.00
(+0.83%)
2,280.00
(+1.86%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
